ArticleFrontiers in oncology2024

Sustained yet non-curative response to lenalidomide in relapsed angioimmunoblastic T-cell lymphoma with acquired chidamide resistance: a case report with 10-year follow-up, genetic insights and literature review.

Juan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.